Egalet Corp

WAYNE, PA · CIK 0001586105 · Biotech · Defunct

Tamper-resistant opioid formulations and abuse-deterrent pain medications

egalet.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$42M
1 Form D · Feb 2019
91 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$42,156,458
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2147KALION, INC.—$6.7M
2148VIRONGY, LLC——
2149EpiBiologics, Inc.—$30M
2150Egalet Corp—$42M
2151Denali Medical II, Inc.—$4.0M
2152KANNALIFE SCIENCES, INC.—$1.5M
2153QRKANSWER LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 11 related persons
  • BARBARA CARLINExecutive Officer
  • LUKE DUSTERDirector
  • ANDREA HESLIN SMILEYDirector
  • TODD HOLMESDirector
  • JOSEPH MCINNISDirector
  • MATTHEW PAULSDirector
  • ROBERT RADIEDirector · Executive Officer
  • PATRICK SHEAExecutive Officer
  • MARK STROBECKExecutive Officer
  • MEGAN TIMMINSExecutive Officer
  • TIMOTHY WALBERTDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.